Partners

Institut Pasteur Korea (IPK)

Institut Pasteur Korea is conceptualized around a virtual “genome to drugs” pipeline. The goal of IPK Korea is to actively implement post-genomic approaches into accelerated drug discovery. Accordingly, IP-Korea is situated at the very fault line between basic research and application.

Expertise related to their role in the project: The Biology of Intracellular Pathogens group has developed new assays based on automated confocal fluorescence microscopy and have adapted them to large scale approaches in order to identify bacterial features, host cell factors and compounds involved in the modulation of the trafficking and growth of M. tuberculosis inside macrophages.

Key Personnel

Dr. Jonathan Cechetto, Dr. Veronica Soloveva, Dr. Priscille Brodin.